C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus
- PMID: 17967469
- DOI: 10.1016/j.neuropharm.2007.09.001
C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus
Abstract
Adenosine A1 receptors are ubiquitous mediators of presynaptic inhibition of neurotransmission in the central nervous system, yet the signalling pathway linking A1 receptor activation and decreased neurotransmitter release remains poorly resolved. We tested the contribution of c-Jun N-terminal kinase (JNK) to adenosine A1 receptor-mediated depression of field excitatory postsynaptic potentials (fEPSPs) in area CA1 of the rat hippocampus. We found that inhibition of JNK with SP600125 or JNK inhibitor V, but not an inactive analogue, attenuated the depression of fEPSPs induced by adenosine, hypoxia, and the A1 receptor agonist N(6)-cyclopentyladenosine (CPA). In contrast, the JNK inhibitor SP600125 did not inhibit GABA(B)-mediated synaptic depression. In support of our electrophysiological findings, Western blot analysis showed that A1 receptor stimulation resulted in a transient increase in JNK phosphorylation in the membrane fraction of hippocampal lysates. The total amount of JNK in the membrane fraction was unchanged by CPA treatment. The increase in phosphorylated JNK induced by A1 receptor stimulation was blocked by the A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), indicating that A1 receptors specifically activate JNK in the hippocampus. Together with functional data indicating that JNK inhibition decreased CPA-induced paired pulse facilitation, these results suggest that JNK activation is necessary for adenosine A1 receptor-mediated synaptic depression occurring at a presynaptic locus The adenosine A1 receptor-JNK signalling pathway may represent a novel mechanism underlying inhibition of neurotransmitter release in the CNS.
Similar articles
-
The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor.Int J Mol Sci. 2020 Dec 30;22(1):320. doi: 10.3390/ijms22010320. Int J Mol Sci. 2020. PMID: 33396826 Free PMC article. Review.
-
Prolonged adenosine A1 receptor activation in hypoxia and pial vessel disruption focal cortical ischemia facilitates clathrin-mediated AMPA receptor endocytosis and long-lasting synaptic inhibition in rat hippocampal CA3-CA1 synapses: differential regulation of GluA2 and GluA1 subunits by p38 MAPK and JNK.J Neurosci. 2014 Jul 16;34(29):9621-43. doi: 10.1523/JNEUROSCI.3991-13.2014. J Neurosci. 2014. PMID: 25031403 Free PMC article.
-
p38 mitogen-activated protein kinase contributes to adenosine A1 receptor-mediated synaptic depression in area CA1 of the rat hippocampus.J Neurosci. 2006 Nov 29;26(48):12427-38. doi: 10.1523/JNEUROSCI.4052-06.2006. J Neurosci. 2006. PMID: 17135404 Free PMC article.
-
Blockade of presynaptic adenosine A1 receptor responses by nitric oxide and superoxide in rat hippocampus.Eur J Neurosci. 2004 Aug;20(3):719-28. doi: 10.1111/j.1460-9568.2004.03502.x. Eur J Neurosci. 2004. PMID: 15255982
-
New insight into A₁ adenosine receptors in diabetes treatment.Curr Pharm Des. 2010;16(38):4237-42. doi: 10.2174/138161210794519066. Curr Pharm Des. 2010. PMID: 21208178 Review.
Cited by
-
Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.J Pharmacol Exp Ther. 2016 Jul;358(1):31-8. doi: 10.1124/jpet.116.232231. Epub 2016 Apr 26. J Pharmacol Exp Ther. 2016. PMID: 27189965 Free PMC article.
-
The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder.BMC Med. 2014 May 7;12:73. doi: 10.1186/1741-7015-12-73. BMC Med. 2014. PMID: 24886127 Free PMC article.
-
The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor.Int J Mol Sci. 2020 Dec 30;22(1):320. doi: 10.3390/ijms22010320. Int J Mol Sci. 2020. PMID: 33396826 Free PMC article. Review.
-
The Anti-Parkinsonian A2A Receptor Antagonist Istradefylline (KW-6002) Attenuates Behavioral Abnormalities, Neuroinflammation, and Neurodegeneration in Cerebral Ischemia: An Adenosinergic Signaling Link Between Stroke and Parkinson's Disease.Int J Mol Sci. 2025 Jun 13;26(12):5680. doi: 10.3390/ijms26125680. Int J Mol Sci. 2025. PMID: 40565142 Free PMC article.
-
Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning.Neurochem Res. 2013 Dec;38(12):2516-23. doi: 10.1007/s11064-013-1164-3. Epub 2013 Oct 8. Neurochem Res. 2013. PMID: 24100927
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous